thimerosal (BTL-TML) / Beech Tree Labs - LARVOL DELTA

Low-dose Oral Thimerosal for the Treatment of Oral Herpes: Clinical Trial Results and Improved Outcome After Post-hoc Analysis. (PubMed, J Evid Based Integr Med) - "Neither clinical trial showed a statistically significant effect of BTL-TML on progression to lesion. However, the post-hoc analysis suggested there is a 48-hour period following UV radiation exposure during which the anti-herpes activity of antivirals such as BTL-TML is reduced. Accordingly, BTL-TML may have promise in subsequent, properly designed and powered clinical trials."

Clinical • Journal • Retrospective data • Herpes Simplex • Infectious Disease • Mood Disorders

BTL-TML-COVID: A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 (clinicaltrials.gov) - P2; N=28; Completed; Sponsor: Beech Tree Labs, Inc.; Recruiting ➔ Completed

Trial completion • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

BTL-TML-COVID: A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 (clinicaltrials.gov) - P2; N=40; Recruiting; Sponsor: Beech Tree Labs, Inc.; Trial completion date: Feb 2021 ➔ Jul 2021; Trial primary completion date: Jan 2021 ➔ Jun 2021

Clinical • Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

BTL-TML-COVID: A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 (clinicaltrials.gov) - P2; N=40; Recruiting; Sponsor: Beech Tree Labs, Inc.; Trial completion date: Oct 2020 ➔ Feb 2021; Trial primary completion date: Oct 2020 ➔ Jan 2021

Clinical • Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease

Beech Tree Labs selects Curavit Clinical Research for fully virtual COVID-19 clinical trial (PRNewswire) - "Beechtree Labs has chosen Curavit Clinical Research for a fully decentralized clinical trial to investigate a promising Covid-19 therapy. The FDA-authorized phase 2 clinical study will evaluate the effect of Beech Tree's BTL-TML therapy on mean duration and severity of disease in 40 outpatients aged 60 years or older with underlying conditions....It is a fully decentralized clinical trial, made possible by applying virtual trial design protocols, digital telehealth technologies, electronic patient reported outcomes (ePRO), and full web and contact center patient support to eliminate the need for in-person office visits."

Trial status • Infectious Disease • Novel Coronavirus Disease

BTL-TML-COVID: A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 (clinicaltrials.gov) - P2; N=40; Recruiting; Sponsor: Beech Tree Labs, Inc.

Clinical • New P2 trial • Infectious Disease • Novel Coronavirus Disease